Clinical significance and function of RDH16 as a tumor‐suppressing gene in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Clinical significance and function of RDH16 as a tumor‐suppressing gene in hepatocellular carcinoma

Published:2019-12-08 Issue:1 Volume:50 Page:110-120
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Zhu Ying‐Hui¹^ORCID,Li Jian‐Biao¹²³,Wu Rui‐Yan¹,Yu Yan¹,Li Xuan¹,Li Zhi‐Ling¹,Zhang Hai‐Liang¹,Feng Gong‐Kan¹,Deng Rong¹,Zhu Xiao‐Feng¹

Affiliation:

1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Sun Yat‐sen University Cancer Center Guangzhou China

2. BGI‐Shenzhen Shenzhen China

3. China National Gene Bank BGI‐Shenzhen Shenzhen China

Funder

National Natural Science Foundation of China

Science and Technology Planning Project of Guangdong Province

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13432

Reference46 articles.

1. Global cancer statistics, 2012

2. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

3. Cancer statistics in China, 2015

4. Hepatocellular Carcinoma

5. Major achievements in hepatocellular carcinoma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinol and retinol binding protein 4 levels and COVID-19: a Mendelian randomization study;BMC Pulmonary Medicine;2024-04-26

2. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy;Current Medicinal Chemistry;2024-02-26

3. Bioinformatics identification of key microRNA correlated genes for the development and prognosis of hepatocellular carcinoma;2024-02-07

4. Longevity‐CancerDB: unlocking the distinctive features and roles of longevity‐associated genes in tumourigenesis;Clinical and Translational Medicine;2024-01

5. RNA biomarkers in cancer therapeutics: The promise of personalized oncology;Advances in Clinical Chemistry;2024